Clinical trial
An Open-label Study of Combination of Cinacalcet and Active Vitamin D Analogue in the Management of Severe Secondary Hyperparathyroidism in Haemodialysis Patients
NCT02338934 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-label Study of Combination of Cinacalcet and Active Vitamin D Analogue in the Management of Severe Secondary Hyperparathyroidism in Haemodialysis Patients
- Lead sponsor
- Penang Hospital, Malaysia
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2015
- Completion date
- January 31, 2017
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
secondary hyperparathyroidism